127.82
1.36%
+1.71
DaVita Inc stock is currently priced at $127.82, with a 24-hour trading volume of 471.11K.
It has seen a +1.36% increased in the last 24 hours and a -7.60% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $126.8 pivot point. If it approaches the $127.9 resistance level, significant changes may occur.
DaVita Inc Stock (DVA) Financials Data
DaVita Inc (DVA) Revenue 2024
DVA reported a revenue (TTM) of $12.14 billion for the quarter ending December 31, 2023, a +4.57% rise year-over-year.
DaVita Inc (DVA) Net Income 2024
DVA net income (TTM) was $691.53 million for the quarter ending December 31, 2023, a +23.40% increase year-over-year.
DaVita Inc (DVA) Cash Flow 2024
DVA recorded a free cash flow (TTM) of $1.49 billion for the quarter ending December 31, 2023, a +55.13% increase year-over-year.
DaVita Inc (DVA) Earnings per Share 2024
DVA earnings per share (TTM) was $7.40 for the quarter ending December 31, 2023, a +28.03% growth year-over-year.
DaVita Inc Stock (DVA) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
STAFFIERI MICHAEL DAVID | Chief Operating Officer, DKC |
Mar 13 '24 |
Option Exercise |
52.41 |
50,000 |
2,620,500 |
102,748 |
Rodriguez Javier | Chief Executive Officer |
Mar 06 '24 |
Option Exercise |
67.80 |
750,000 |
50,850,000 |
1,244,480 |
ACKERMAN JOEL | CFO and Treasuer |
Mar 06 '24 |
Option Exercise |
52.41 |
55,000 |
2,882,550 |
195,360 |
STAFFIERI MICHAEL DAVID | Chief Operating Officer, DKC |
Mar 06 '24 |
Option Exercise |
52.41 |
50,000 |
2,620,500 |
87,687 |
Rodriguez Javier | Chief Executive Officer |
Feb 28 '24 |
Option Exercise |
67.80 |
50,000 |
3,390,000 |
531,300 |
Rodriguez Javier | Chief Executive Officer |
Feb 27 '24 |
Sale |
126.87 |
7,397 |
938,467 |
481,300 |
Rodriguez Javier | Chief Executive Officer |
Feb 26 '24 |
Option Exercise |
67.80 |
450,000 |
30,510,000 |
889,002 |
Rodriguez Javier | Chief Executive Officer |
Feb 26 '24 |
Sale |
126.11 |
67,603 |
8,525,130 |
488,697 |
STAFFIERI MICHAEL DAVID | Chief Operating Officer, DKC |
Feb 21 '24 |
Option Exercise |
52.41 |
100,000 |
5,241,000 |
137,687 |
ACKERMAN JOEL | CFO and Treasuer |
Feb 21 '24 |
Option Exercise |
52.41 |
55,000 |
2,882,550 |
178,726 |
DaVita Inc Stock (DVA) Latest News
DaVita HealthCare (DVA) Advances While Market Declines: Some Information for Investors
Zacks Investment Research
Reasons Why You Should Retain Masimo (MASI) Stock for Now
Zacks Investment Research
CVRx's (CVRX) Latest Data Favors Barostim's Long-Term Benefits
Zacks Investment Research
GE HealthCare's (GEHC) Voluson to Aid Women's Health Imaging
Zacks Investment Research
AtriCure's (ATRC) cryoSPHERE+ Probe to Aid in Pain Management
Zacks Investment Research
Intuitive Surgical (ISRG) Q1 Earnings Beat, Procedures Robust
Zacks Investment Research
About DaVita Inc
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company operates DaVita Rx, a pharmacy that provides oral medications and medication management services to patients with ESRD; disease management services; vascular access services; clinical research programs; physician services; and direct primary care services. As of December 31, 2017, it provided dialysis and administrative services in the United States through a network of 2,510 outpatient dialysis centers serving approximately 197,800 patients; and operated 237 outpatient dialysis centers located in 11 countries outside of the United States. Further, the company provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was founded in 1994 and is headquartered in Denver, Colorado.
Cap:
|
Volume (24h):